Investment Rating - The report assigns a "Buy" rating to the company, indicating a potential upside of 15% to 35% from the current price [8]. Core Insights - The company achieved a revenue of RMB 5.25 billion in 2024, representing a year-on-year growth of 21%, with a net profit of RMB 630 million, up 45.7% year-on-year [5]. - In Q1 2025, the company reported a revenue of RMB 1.48 billion, a 34.8% increase year-on-year, and a net profit of RMB 200 million, reflecting a 37.7% growth [5]. - The company maintains strong growth momentum, driven by its proprietary brands, with significant sales increases in both domestic and international markets [5]. Financial Performance Summary - The company’s net profit is projected to grow from RMB 795 million in 2025 to RMB 1.15 billion in 2027, with year-on-year growth rates of 27%, 21.3%, and 19% respectively [7]. - Earnings per share (EPS) are expected to rise from RMB 1.99 in 2025 to RMB 2.87 in 2027, with corresponding price-to-earnings (P/E) ratios decreasing from 50x to 34x over the same period [7]. - The company’s revenue is forecasted to increase from RMB 6.59 billion in 2025 to RMB 9.21 billion in 2027, indicating a robust growth trajectory [10]. Business Segmentation - The product mix consists of 51.3% staple foods and 47.35% snacks, with health products and others making up 0.88% [2]. - The proprietary brand "Mifudi" continues to lead in sales, with a 190% year-on-year increase for its high-end brand "Fuleijiate" and a 150% increase for "Bafu" [5]. Dividend Policy - The company has proposed a cash dividend of RMB 2.5 per 10 shares, reflecting its commitment to returning value to shareholders [5].
乖宝宠物：24年报及25Q1点评：业绩强劲，自主品牌出色-20250423